Clearmind Medicine Form 13G Filed by Gainor Lewis Berray
A Schedule 13G filing for Clearmind Medicine Inc. was filed by Gainor Lewis Berray. The body lists the filing date as October 27, 20.
Related stories
Making Science Announces Webinar on Third-Quarter Results
Making Science announced a webinar to present its third-quarter results.
M impact | EQUITY | Oct 29, 2026, 05:32 PM UTC
OSE Immunotherapeutics Reports Phase 2 Tedopi Combo Survival Data
In metastatic NSCLC, one-year overall survival was 47% with Tedopi plus docetaxel and 46% with Tedopi plus nivolumab, versus 29% with docetaxel. Median overall survival was 11.9 an
M impact | EQUITY | Oct 29, 2026, 05:32 PM UTC
KBR Reports Third-Quarter 2026 Revenue of $2.03 Billion, EPS of $1.06
Revenue rose 5% year over year to $2.03 billion, net income increased 16.2% to $136 million, and diluted EPS climbed 17.8% to $1.06. Sustainable Technology Solutions growth offset
M impact | EQUITY | Oct 29, 2026, 05:32 PM UTC
Canada to Take Up to CA$1.6 Billion Equity Stake in Cohere
The Canadian government is taking an equity stake of up to CA$1.6 billion in Toronto-based Cohere.
M impact | EQUITY | Oct 29, 2026, 05:32 PM UTC
OSE Immunotherapeutics Says Tedopi Combinations Meet Phase 2 Trial Primary Endpoint
OSE Immunotherapeutics said Tedopi combinations met the primary endpoint in a Phase 2 lung cancer trial.
M impact | EQUITY | Oct 29, 2026, 05:30 PM UTC
Glaukos shares soar 31% amid heavy trading
Glaukos shares rose 31% amid heavy trading.
M impact | EQUITY | Oct 29, 2026, 05:30 PM UTC